Provided By GlobeNewswire
Last update: Jun 4, 2025
PHILADELPHIA and VANCOUVER, British Columbia, June 04, 2025 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (Nasdaq: BCTX, BCTXW, BCTXZ), (TSX: BCT) (“BriaCell” or the “Company”), a clinical-stage biotechnology company developing novel immunotherapies to transform cancer care, announces today that the Company will be conducting two virtual investor presentations on Thursday, June 12, at 12:00 PM EDT and on Thursday, June 26, at 12:00 PM EDT, arranged by Renmark Financial Communications Inc. Briacell Therapeutics Corp. welcomes stakeholders, investors, and other individual followers to register and attend these live events.
Read more at globenewswire.comNASDAQ:BCTXZ (10/22/2025, 11:10:51 AM)
0.4499
+0.02 (+4.41%)
NASDAQ:BCTXW (10/22/2025, 10:42:44 AM)
0.05
-0.01 (-16.67%)
NASDAQ:BCTX (10/22/2025, 11:16:01 AM)
12.0616
-0.71 (-5.55%)
Find more stocks in the Stock Screener